Primary ChAdOx1 vaccination fails to reactivate pre-existing, cross-reactive T cells

被引：0
|
作者：
Henze, L. [1 ,2 ,3 ,4 ,5 ]
Braun, J. [1 ,2 ,3 ,4 ,5 ]
Meyer-Arndt, L. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Juerchott, K. [1 ,2 ,3 ,4 ,5 ]
Schlotz, M. [9 ,10 ]
Michel, J. [12 ]
Grossegesse, M. [12 ]
Mangold, M. [1 ,2 ,3 ,4 ,5 ]
Dingeldey, M. [1 ,2 ,3 ,4 ,5 ]
Kruse, B. [1 ,2 ,3 ,4 ,5 ]
Holenya, P. [13 ]
Mages, N. [1 ,2 ,3 ,4 ,5 ]
Reimer, U. [13 ]
Eckey, M. [13 ]
Timmermann, B. [14 ]
Klein, F. [9 ,10 ,15 ,16 ]
Nitsche, A. [11 ,12 ]
Giesecke-Thiel, C. [14 ]
Loyal, L. [1 ,2 ,3 ,4 ,5 ]
Thiel, A. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Tech Univ Berlin, Si M Simulierte Mensch Sci Framework, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Berlin Inst Hlth, Regenerat Immunol & Aging, BIH Immun, Berlin, Germany
[6] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[7] Berlin Inst Hlth, Berlin, Germany
[8] Charite Univ Med Berlin, Dept Neurol Expt Neurol, Berlin, Germany
[9] Univ Cologne, Expt Immunol Lab, Fac Med, Inst Virol, Cologne, Germany
[10] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[11] Robert Koch Inst, Highly Pathogen Viruses, Ctr Biol Threats & Special Pathogens, WHO Reference Lab SARS CoV, Berlin, Germany
[12] Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, Berlin, Germany
[13] JPT Peptide Technol GmbH, Berlin, Germany
[14] Max Planck Inst Mol Genet, Berlin, Germany
[15] German Ctr Infect Res DZIF, Partnersite Bonn Cologne, Cologne, Germany
[16] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P69
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] Pre-existing SARS-CoV-2-reactive CD4+ T cells are established and highly functional in early childhood
    Olofsson, Anna
    Humbert, Marion
    Niessl, Julia
    Hodcroft, Emma
    Gao, Yu
    Sohlberg, Ebba
    Malmberg, Karl-Johan
    Lund-Johansen, Fritjof
    Bjorkhem-Bergman, Linda
    Jenmalm, Maria C.
    Ljunggren, Hans-Gustaf
    Buggert, Marcus
    Karlsson, Annika C.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [32] Cross-reactive CD4+T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
    Loyal, Lucie
    Braun, Julian
    Henze, Larissa
    Kruse, Beate
    Dingeldey, Manuela
    Reimer, Ulf
    Kern, Florian
    Schwarz, Tatjana
    Arndt, Lil Meyer
    Thiel, Andreas
    Thiel, Claudia Giesecke
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 140 - 140
  • [33] Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
    Loyal, Lucie
    Braun, Julian
    Henze, Larissa
    Kruse, Beate
    Dingeldey, Manuela
    Reimer, Ulf
    Kern, Florian
    Schwarz, Tatjana
    Mangold, Maike
    Unger, Clara
    Dorfler, Friederike
    Kadler, Shirin
    Rosowski, Jennifer
    Gurcan, Kubrah
    Uyar-Aydin, Zehra
    Frentsch, Marco
    Kurth, Florian
    Schnatbaum, Karsten
    Eckey, Maren
    Hippenstiel, Stefan
    Hocke, Andreas
    Muller, Marcel A.
    Sawitzki, Birgit
    Miltenyi, Stefan
    Paul, Friedemann
    Mall, Marcus A.
    Wenschuh, Holger
    Voigt, Sebastian
    Drosten, Christian
    Lauster, Roland
    Lachman, Nils
    Sander, Leif-Erik
    Corman, Victor M.
    Rohmel, Jobst
    Meyer-Arndt, Lil
    Thiel, Andreas
    Giesecke-Thiel, Claudia
    SCIENCE, 2021, 374 (6564) : 171 - +
  • [34] INDUCTION OF BROADLY CROSS-REACTIVE CYTOTOXIC T-CELLS RECOGNIZING AN HIV-1 ENVELOPE DETERMINANT
    TAKAHASHI, H
    NAKAGAWA, Y
    PENDLETON, CD
    HOUGHTEN, RA
    YOKOMURO, K
    GERMAIN, RN
    BERZOFSKY, JA
    SCIENCE, 1992, 255 (5042) : 333 - 336
  • [35] Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals
    Jo, Norihide
    Zhang, Rui
    Ueno, Hideki
    Yamamoto, Takuya
    Weiskopf, Daniela
    Nagao, Miki
    Yamanaka, Shinya
    Hamazaki, Yoko
    FRONTIERS IN AGING, 2021, 2
  • [36] Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive
    Friberg, Heather
    Burns, Lynne
    Woda, Marcia
    Kalayanarooj, Siripen
    Endy, Timothy P.
    Stephens, Henry A. F.
    Green, Sharone
    Rothman, Alan L.
    Mathew, Anuja
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (01): : 122 - 129
  • [37] SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination
    Teng, Shishan
    Hu, Yabin
    Wang, You
    Tang, Yinggen
    Wu, Qian
    Zheng, Xingyu
    Lu, Rui
    Pan, Dong
    Liu, Fen
    Xie, Tianyi
    Wu, Chanfeng
    Li, Yi-Ping
    Liu, Wenpei
    Qu, Xiaowang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Recent Common Cold Does Not Reliably Protect from Re-Infection and Fails to Cross-Protect Fifteen Weeks Later, Despite Involvement of Cross-Reactive T Cells
    Muehling, Lyndsey
    Turner, Ronald
    Paul, Alberta
    Denby-Taylor, Cheree
    Kwok, William
    Woodfolk, Judith
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB164 - AB164
  • [39] Unveiling the significance of cross-reactive bone marrow resident memory T cells in immune responses: Insights from SARS-CoV-2 and vaccination
    Li, Jinchan
    Reinke, Simon
    Shen, Yu
    Wang, Zixu
    Perka, Carsten
    Sebastian, Hardt
    Hipfl, Christian
    Alexander, Tobias
    Chang, Hyun-Dong
    Radbruch, Helena
    Qin, Zhihai
    Radbruch, Andreas
    Dong, Jun
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1245 - 1245
  • [40] Loss of pre-existing tumor-specific T-cells and increase in regulatory T-cells after peptide vaccination in combination with PADRE, CpG 7909, and Montanide ISA51
    Kuball, Jurgen
    deBoer, Karin
    Wagner, Eva
    Wattad, Mohammed
    Antunes, Edite
    Lotz, Carina
    vanDorp, Suzanne
    Holl, Samantha
    Huber, Christoph
    Greenberg, Philip D.
    Heit, Wolfgang
    Theobald, Matthias
    JOURNAL OF IMMUNOLOGY, 2009, 182
12345